ORAL ALBENDAZOLE FOR THE TREATMENT OF CUTANEOUS LARVA MIGRANS

被引:42
作者
JONES, SK
REYNOLDS, NJ
OLIWIECKI, S
HARMAN, RRM
机构
[1] Department of Dermatology, Bristol Royal Infirmary
关键词
D O I
10.1111/j.1365-2133.1990.tb08245.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Cutaneous larva migrans is becoming more common in the U.K. with the popularity of tropical countries as holiday destinations. We describe the increasing use of a new benzimidazole derivative, albendazole, which is very effective in the treatment of cutaneous larva migrans. In contrast to thiabendazole, it is virtually free from side-effects and should, we feel, become the treatment of choice for this condition.
引用
收藏
页码:99 / 101
页数:3
相关论文
共 7 条
  • [1] COULAUD JP, 1982, B SOC PATHOL EXOT, V75, P534
  • [2] HARMAN RRM, 1986, TXB DERMATOLOGY, V2, P994
  • [3] HITCH J M, 1960, South Med J, V53, P447, DOI 10.1097/00007611-196004000-00013
  • [4] ORIHEULA A, 1988, MED PRIVADA, V4, P227
  • [5] SAIMOT AG, 1983, LANCET, V2, P652
  • [6] SIVAYATHORN A, 1986, 9 INT C INF PAR DIS
  • [7] CREEPING ERUPTION STOPPED IN ITS TRACKS BY ALBENDAZOLE
    WILLIAMS, HC
    MONK, B
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1989, 14 (05) : 355 - 356